Valuation: North China Pharmaceutical Company.Ltd

Market Cap 8.1B 1.21B 1.1B 1.01B 917M 1.73B 114B 1.78B 12.15B 4.83B 60.97B 4.55B 4.46B 194B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.77B 2.66B 2.41B 2.22B 2.01B 3.8B 250B 3.91B 26.67B 10.6B 134B 9.99B 9.78B 426B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
43.52%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-1.67%
1 week-2.88%
Current month+3.74%
1 month-28.81%
3 months-5.79%
6 months-9.92%
Current year-14.65%
1 week 4.72
Extreme 4.72000000
4.88
1 month 4.43
Extreme 4.43
6.9
Current year 4.11
Extreme 4.11
6.9
1 year 4.11
Extreme 4.11
6.9
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 2025-11-27
Director of Finance/CFO 46 2024-04-09
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 2016-03-21
Director/Board Member 53 2021-04-22
Director/Board Member 54 2022-10-11
Date Insider Type Main position Quantity % Market Cap. Importance
2/25/25 Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-2.88%-23.75%-20.00% 1.23B
-0.70%+4.58%+40.23%+138.79% 1,280B
+1.11%+4.11%+45.85%+92.54% 675B
-0.18%+2.15%+26.25%+112.46% 521B
+1.14%+3.78%+39.98%+71.70% 386B
-0.16%+0.01%+60.69%+44.94% 363B
+1.11%+0.07%+28.19%+60.05% 301B
+0.24%-0.80%+3.05%+38.06% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 211B
Average -0.04%+0.08%+29.55%+73.45% 428B
Weighted average by Cap. +0.06%+0.57%+37.49%+97.29%

Financials

2024 2025
Net sales 9.87B 1.48B 1.34B 1.23B 1.12B 2.11B 139B 2.17B 14.81B 5.89B 74.3B 5.55B 5.43B 237B 9.24B 1.38B 1.25B 1.16B 1.05B 1.97B 130B 2.03B 13.87B 5.51B 69.58B 5.2B 5.08B 221B
Net income 127M 19.02M 17.2M 15.88M 14.37M 27.12M 1.79B 27.94M 191M 75.74M 956M 71.4M 69.87M 3.04B 183M 27.42M 24.8M 22.89M 20.72M 39.1M 2.58B 40.27M 275M 109M 1.38B 103M 101M 4.39B
Net Debt 9.79B 1.47B 1.33B 1.22B 1.11B 2.09B 138B 2.15B 14.69B 5.84B 73.7B 5.5B 5.39B 235B 9.67B 1.45B 1.31B 1.21B 1.09B 2.07B 136B 2.13B 14.52B 5.77B 72.83B 5.44B 5.32B 232B
Projected Income Statement - Annual - North China Pharmaceutical Company.Ltd
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
26-11-12 CN¥4.720 -1.67% 36,525,565
26-11-11 CN¥4.800 -0.41% 33,340,560
26-11-10 CN¥4.820 -0.21% 39,713,111
26-11-09 CN¥4.830 +1.05% 42,949,979
26-11-06 CN¥4.780 -1.65% 42,728,582

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - North China Pharmaceutical Company.Ltd
  1. Stock Market
  2. Stocks
  3. 600812 Stock